DK1553832T3 - Præparater og fremgangsmåder til celleseparering - Google Patents

Præparater og fremgangsmåder til celleseparering

Info

Publication number
DK1553832T3
DK1553832T3 DK03759533T DK03759533T DK1553832T3 DK 1553832 T3 DK1553832 T3 DK 1553832T3 DK 03759533 T DK03759533 T DK 03759533T DK 03759533 T DK03759533 T DK 03759533T DK 1553832 T3 DK1553832 T3 DK 1553832T3
Authority
DK
Denmark
Prior art keywords
methods
cell separation
preparations
separation preparations
reagents
Prior art date
Application number
DK03759533T
Other languages
Danish (da)
English (en)
Inventor
Daniel P Collins
Joel H Hapke
Carol A Buchert
Original Assignee
Bioe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioe Inc filed Critical Bioe Inc
Application granted granted Critical
Publication of DK1553832T3 publication Critical patent/DK1553832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03759533T 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering DK1553832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41469202P 2002-09-27 2002-09-27
PCT/US2003/030265 WO2004029208A2 (fr) 2002-09-27 2003-09-26 Compositions et procedes de separation de cellules

Publications (1)

Publication Number Publication Date
DK1553832T3 true DK1553832T3 (da) 2007-10-01

Family

ID=32043402

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03759533T DK1553832T3 (da) 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering

Country Status (13)

Country Link
US (1) US6933148B2 (fr)
EP (1) EP1553832B1 (fr)
JP (1) JP4344696B2 (fr)
CN (1) CN100350040C (fr)
AT (1) ATE366801T1 (fr)
AU (1) AU2003275260B2 (fr)
CA (1) CA2499826C (fr)
DE (1) DE60314898T2 (fr)
DK (1) DK1553832T3 (fr)
IL (1) IL167624A (fr)
MX (1) MXPA05003260A (fr)
RU (1) RU2346039C2 (fr)
WO (1) WO2004029208A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1377353A4 (fr) * 2001-04-10 2005-08-31 Bioergonomics Inc Compositions et methodes de separation cellulaire
CN100556546C (zh) * 2003-02-13 2009-11-04 贝克顿·迪金森公司 在血液收集过程中去除成分的装置及其使用
EP1747265B1 (fr) * 2004-04-23 2011-04-20 BioE LLC Cellules précurseurs de plusieurs lignages
US8263404B2 (en) * 2005-04-08 2012-09-11 Medical Discovery Partners Llc Method for enriching rare cell subpopulations from blood
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
EP2066349B1 (fr) 2006-09-08 2012-03-28 MedImmune, LLC Anticorps anti-cd19 humanises et leur utilisation dans le traitement des tumeurs, de la transplantation et des maladies auto-immunes
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
MX2010013265A (es) * 2008-06-06 2011-02-24 Baylor Res Inst Anticuerpos anti-cd8 bloquean cebado de efectores citotoxicos y conducen a generacion de celulas t cd8+ reguladoras.
CN102149473B (zh) 2008-07-21 2014-12-31 贝克顿·迪金森公司 密度相分离装置
CA2731156C (fr) 2008-07-21 2013-09-24 Becton, Dickinson And Company Dispositif de separation de phases par densite
ES2452534T3 (es) 2008-07-21 2014-04-01 Becton, Dickinson And Company Dispositivo de separación de fases de densidad
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒
PL3821980T3 (pl) 2009-05-15 2023-02-20 Becton, Dickinson And Company Urządzenie do rozdzielania faz gęstości
KR101834687B1 (ko) * 2009-09-15 2018-03-05 고쿠리츠다이가쿠호우진 도쿄다이가쿠 분화 세포의 신규 제조법
US20130288227A1 (en) * 2010-11-01 2013-10-31 Daniel P. Collins Methods and compositions for cell separation of blood tissues
EP2643694B1 (fr) * 2010-11-24 2018-01-03 Litron Laboratories Ltd. Évaluation de mutation génétique in vivo rapide sur la base du gène pig-a
EP2681555B1 (fr) 2011-02-25 2020-04-08 Benaroya Research Institute Détection d'une allergie
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
DK2597153T3 (en) * 2011-11-25 2016-12-05 Miltenyi Biotec Gmbh Method for cell separation
WO2014165433A1 (fr) * 2013-04-01 2014-10-09 Bhc Technology Holdings Llc Compositions de séparation de cellules et procédés pour séparer et récupérer des cellules thérapeutiques dans un tissu sanguin
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
CN108586612A (zh) * 2018-03-27 2018-09-28 深圳联合医学科技有限公司 一种适用于检测人外周血表达cd161分子亚群淋巴细胞的单克隆抗体的制备方法
RU2020122145A (ru) * 2020-07-03 2022-01-04 Петр Иванович Никитин Композиция и способ для улучшения эффективности или снижения побочных эффектов терапевтического агента, используемого для доставки нуклеиновых кислот
CN118388650B (zh) * 2024-06-28 2024-08-27 杭州赛基生物科技有限公司 一种抗CD235a单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5840502A (en) 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5877299A (en) 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US6146628A (en) 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
US6491917B1 (en) 1998-07-31 2002-12-10 Stemcell Technologies Inc. Antibody composition for debulking blood and bone marrow samples from CML patients
US6153113A (en) 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US6448075B1 (en) * 1999-05-28 2002-09-10 Stemcell Technologies Inc. Method for separating cells using immunorosettes
EP1377353A4 (fr) * 2001-04-10 2005-08-31 Bioergonomics Inc Compositions et methodes de separation cellulaire

Also Published As

Publication number Publication date
RU2005112731A (ru) 2006-01-20
MXPA05003260A (es) 2005-09-12
WO2004029208A2 (fr) 2004-04-08
EP1553832B1 (fr) 2007-07-11
RU2346039C2 (ru) 2009-02-10
WO2004029208A3 (fr) 2005-04-14
DE60314898D1 (de) 2007-08-23
CA2499826C (fr) 2015-03-24
ATE366801T1 (de) 2007-08-15
AU2003275260B2 (en) 2008-01-24
JP4344696B2 (ja) 2009-10-14
IL167624A (en) 2009-12-24
DE60314898T2 (de) 2008-03-13
JP2006500932A (ja) 2006-01-12
US6933148B2 (en) 2005-08-23
US20040062766A1 (en) 2004-04-01
CN100350040C (zh) 2007-11-21
CA2499826A1 (fr) 2004-04-08
AU2003275260A1 (en) 2004-04-19
CN1735346A (zh) 2006-02-15
EP1553832A4 (fr) 2006-02-01
EP1553832A2 (fr) 2005-07-20

Similar Documents

Publication Publication Date Title
DK1553832T3 (da) Præparater og fremgangsmåder til celleseparering
ATE493186T1 (de) Zelltrennungszusammensetzungen und -verfahren
ATE536187T1 (de) Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen
GB9709728D0 (en) Single step method
WO2005021728A3 (fr) Populations de cellules progenitrices et de cellules souches pancreatiques enrichies, methodes d'identification, d'isolement et d'enrichissement de ces populations
WO2004063362A3 (fr) Proteines de la progression du cycle cellulaire
ATE512666T1 (de) Hla-bindende peptide und ihre verwendungen
SG153699A1 (en) Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
EP1730276B8 (fr) Procede, puce, dispositif et systeme permettant d'extraire des matieres biologiques
DK1532261T3 (da) Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte
TW200801039A (en) Separation methods
WO2004111075A3 (fr) Compositions et procedes utilisant des polypeptides a cadre de lecture differents dans le traitement du cancer et de maladies infectieuses
EP2117592A4 (fr) Procedes et compositions destines a reduire des populations cellulaires specifiques dans du sang et/ou des tissus
IL180531A0 (en) Novel sequence for improving expression of nucleic acid
ATE519536T1 (de) Methode zum trennen von zellen
DK1723233T3 (da) Fremgangsmåde til berigelse og/eller adskillelse prokaryotisk DNA ved hjælp af et protein, som specifikt binder DNA indeholdende ikke-methylerede CPG-motiver
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular
WO2007127659A3 (fr) Méthodes et compositions pour la séparation de cellules
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
AU7963901A (en) Method for electrophoretically separating membrane proteins
DK1576157T3 (da) Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme
EP1581797A4 (fr) Procedes de detection, analyse et isolation de proteines naissantes
NO20065651L (no) Spesifikke bindingsmedlemmer
WO2004072262A3 (fr) Cellules presentant l'antigene cd14+ de culture
DK1230261T3 (da) NY-ESO-1 Nonapeptidderivater og anvendelser af disse